COLL vs COO: fair value comparison
Collegium Pharmaceutical, Inc. and The Cooper Companies, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COLL currently sits closer to the top of our ranking by discount to fair value.
| COLL | COO | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.19 | $54.37 |
| 12-month range | $21.53–$49.84 | $53.27–$84.32 |
| Rank by discount to fair value | #6 of 108 Healthcare | #8 of 108 Healthcare |
| Quality grade | B | B |
| Leverage | High | Low |
| Margin trend | Expanding | Contracting |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: COLL fair value analysis · COO fair value analysis